BioSenic S.A.

Research BioSenic S.A. (BIOS) on Bullrun: market cap EUR 1.31M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerBIOS
• ExchangeBR
• CountryBelgium
• SectorHealthcare
• IndustryBiotechnology
• CurrencyEUR
• Market capEUR 1.31M
• Financial periodFY2023
• Net income-EUR 28.78M
• Free cash flow-EUR 3.47M

Valuation Snapshot

latest market cap is EUR 1.31M.

About BioSenic S.A.

BioSenic S.A., a biotechnology company, develops cell therapy products and treatments for autoimmune and inflammatory diseases in Belgium and France. The company offers arsenic trioxide (ATO) and oral arsenic trioxide (OATO) platforms. It also provides medicinal products, including ArsciMed, an intravenous drug to treat autoimmune diseases. In addition, the company develops 4P004v which is in Phase I clinical trial for veterinary use. BioSenic S.A. is headquartered in Saintes, Belgium.

Frequently asked questions

What is BioSenic S.A.'s market cap?

BioSenic S.A.'s market capitalization is EUR 1.31M.

What does BioSenic S.A. do?

BioSenic S.A., a biotechnology company, develops cell therapy products and treatments for autoimmune and inflammatory diseases in Belgium and France. The company offers arsenic trioxide (ATO) and oral arsenic trioxide (OATO) platforms.